Literature DB >> 18983981

Crystal structure of human mono-phosphorylated ERK1 at Tyr204.

Takayoshi Kinoshita1, Ikuyo Yoshida, Setsu Nakae, Kouki Okita, Masaki Gouda, Mamoru Matsubara, Koichi Yokota, Hiroshi Ishiguro, Toshiji Tada.   

Abstract

Extracellular signal-regulated kinase (ERK) is a member of the MAP kinase family, and can regulate several cellular responses. The isoforms ERK1 and ERK2 have markedly similar amino acid sequences, but exhibit distinctive physiological functions. As well as ERK2, ERK1 was auto- and mono-phosphorylated at Tyr204 in the activation loop during Escherichia coli production, resulting in basal level activity, approximately 500-fold less compared with fully-active ERK1 dual-phosphorylated at Thr202 and Tyr204. Crystal structure demonstrated that the mono-phosphorylated ERK1 kinase possessed a novel conformation distinguishable from the un-phosphorylated (inactive) and the dual-phosphorylated (full-active) forms. The characteristic structural features in both the C-helix and the activation loop likely contribute to the basal activity of the mono-phosphorylated ERK1. The structural dissection of ERK1 compared to ERK2 suggests that the structural differences in the D-motif binding site and in the backside binding site are putative targets for development of selective ERK1/ERK2 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983981     DOI: 10.1016/j.bbrc.2008.10.127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  (+)-2-(1-Hydroxyl-4-oxocyclohexyl) ethyl caffeate suppresses solar UV-induced skin carcinogenesis by targeting PI3K, ERK1/2, and p38.

Authors:  Do Young Lim; Mee-Hyun Lee; Seung Ho Shin; Hanyoung Chen; Joohyun Ryu; Lei Shan; Honglin Li; Ann M Bode; Wei-Dong Zhang; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-20

3.  Docking-based virtual screening of Brazilian natural compounds using the OOMT as the pharmacological target database.

Authors:  Ana Paula Carregal; Flávia V Maciel; Juliano B Carregal; Bianca Dos Reis Santos; Alisson Marques da Silva; Alex G Taranto
Journal:  J Mol Model       Date:  2017-03-11       Impact factor: 1.810

4.  Importance of domain closure for the autoactivation of ERK2.

Authors:  Daniel Barr; Taiji Oashi; Kimberly Burkhard; Sarah Lucius; Ramin Samadani; Jun Zhang; Paul Shapiro; Alexander D MacKerell; Arjan van der Vaart
Journal:  Biochemistry       Date:  2011-08-25       Impact factor: 3.162

5.  Distinct patterns of activation-dependent changes in conformational mobility between ERK1 and ERK2.

Authors:  Adam Y Ring; Kevin M Sours; Thomas Lee; Natalie G Ahn
Journal:  Int J Mass Spectrom       Date:  2011-04       Impact factor: 1.986

6.  Sequence alignment reveals possible MAPK docking motifs on HIV proteins.

Authors:  Perry Evans; Ahmet Sacan; Lyle Ungar; Aydin Tozeren
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

7.  Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancer.

Authors:  Jin-Qiu Chen; Jih-Hsiang Lee; Michelle A Herrmann; Kang-Seo Park; Madeleine R Heldman; Paul K Goldsmith; Yisong Wang; Giuseppe Giaccone
Journal:  Mol Cancer Ther       Date:  2013-08-26       Impact factor: 6.261

8.  Analysis of conditions affecting auto-phosphorylation of human kinases during expression in bacteria.

Authors:  Amit Shrestha; Garth Hamilton; Eric O'Neill; Stefan Knapp; Jonathan M Elkins
Journal:  Protein Expr Purif       Date:  2011-10-01       Impact factor: 1.650

9.  X-ray crystal structure of ERK5 (MAPK7) in complex with a specific inhibitor.

Authors:  Jonathan M Elkins; Jing Wang; Xianming Deng; Michael J Pattison; J Simon C Arthur; Tatiana Erazo; Nestor Gomez; Jose M Lizcano; Nathanael S Gray; Stefan Knapp
Journal:  J Med Chem       Date:  2013-05-17       Impact factor: 7.446

10.  Arbitrary protein-protein docking targets biologically relevant interfaces.

Authors:  Juliette Martin; Richard Lavery
Journal:  BMC Biophys       Date:  2012-05-06       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.